Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q3
$4.8M Sell
34,200
-15,700
-31% -$2.05M ﹤0.01% 2077
2014
Q2
$5.91M Buy
49,900
+19,700
+65% +$2.28M ﹤0.01% 1807
2014
Q1
$3.73M Sell
30,200
-56,000
-65% -$6.79M ﹤0.01% 2149
2013
Q4
$9.83M Sell
86,200
-2,700
-3% -$307K 0.01% 1263
2013
Q3
$9.95M Sell
88,900
-60,900
-41% -$6.6M 0.01% 1133
2013
Q2
$14.8M Buy
+149,800
New +$15.5M 0.02% 806

Other funds holding AMGN

UBS's AMGN Position: Q3 2014 in Review

UBS increased its Amgen (AMGN) stake by 186% in Q3 2014, buying an estimated $387M and bringing the position to 4,556,244 shares worth $640M. The position accounts for 0.47% of the portfolio, ranked #25.

UBS first reported a position in AMGN in Q2 2013 and has held it in 6 quarters since. 1,222 funds tracked by Wall St. Rank hold AMGN as of Q3 2014.

  • UBS held 4,556,244 shares of Amgen worth $640M as of Q3 2014.
  • UBS bought 2,962,203 Amgen shares in Q3 2014, an estimated $387M.
  • Amgen made up 0.47% of UBS's portfolio in Q3 2014, its #25 holding.
  • UBS first reported a position in Amgen in Q2 2013 and has held it in 6 quarters since.
  • 1,222 funds tracked by Wall St. Rank held Amgen as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.